share_log

Angelalign Technology Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Angelalign Technology Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

时代天使(临时代码)科技股份有限公司的收益低于分析师的预期:以下是分析师的预测。
Simply Wall St ·  08/24 20:56

Shareholders of Angelalign Technology Inc. (HKG:6699) will be pleased this week, given that the stock price is up 16% to HK$61.40 following its latest half-year results. Statutory earnings per share disappointed, coming in -51% short of expectations, at CN¥0.13. Fortunately revenue performance was a lot stronger at CN¥861m arriving 18% ahead of predictions. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

本周,时代天使科技股份有限公司(HKG:6699)的股价上涨了16%,至61.40港元,使股东们感到高兴。这是该公司最新的半年度业绩发布之后的情况。尽管法定每股收益令人失望,低于预期的-51%,为0.13元人民币。幸运的是,营业收入表现要好得多,为86100万人民币,超出预期的18%。在结果公布后,分析师们更新了他们的收益模型,很想知道他们是否认为公司的前景发生了巨大的变化,或者一切照旧。我们认为读者可能会发现有趣的是,看到分析师对明年的(法定)盈利预测。

1724536916880
SEHK:6699 Earnings and Revenue Growth August 25th 2024
港交所:6699股票的盈利和营业收入增长2024年8月25日

Taking into account the latest results, the consensus forecast from Angelalign Technology's 13 analysts is for revenues of CN¥1.85b in 2024. This reflects an okay 7.3% improvement in revenue compared to the last 12 months. Per-share earnings are expected to jump 70% to CN¥0.44. Yet prior to the latest earnings, the analysts had been anticipated revenues of CN¥1.75b and earnings per share (EPS) of CN¥0.43 in 2024. There doesn't appear to have been a major change in sentiment following the results, other than the modest lift to revenue estimates.

考虑到最新的业绩,时代天使科技的13位分析师共识预测2024年营业收入为18.5亿元人民币。与过去12个月相比,这意味着营业收入有7.3%的改善。预计每股收益将增长70%,至0.44元人民币。然而,在最新业绩公布之前,分析师们预期2024年的营业收入为17.5亿元人民币,每股收益为0.43元人民币。除了对营业收入预测的稍微提升外,似乎没有出现明显的情绪变化。

It may not be a surprise to see thatthe analysts have reconfirmed their price target of HK$84.70, implying that the uplift in revenue is not expected to greatly contribute to Angelalign Technology's valuation in the near term. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Angelalign Technology analyst has a price target of HK$104 per share, while the most pessimistic values it at HK$64.14. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting Angelalign Technology's growth to accelerate, with the forecast 15% annualised growth to the end of 2024 ranking favourably alongside historical growth of 12% per annum over the past three years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 21% per year. It seems obvious that, while the future growth outlook is brighter than the recent past, Angelalign Technology is expected to grow slower than the wider industry.

我们可以从更大的视角来看待这些估计,比如将预测与过去的业绩进行比较,以及与行业中其他公司的预测相比,预测是更看好还是更保守。分析师们肯定希望时代天使的增长加速,预测将其年均增长率达到15%,与过去三年每年12%的历史增长率相比,表现出色。相比之下,我们的数据显示,同行业其他被分析师覆盖的公司预计每年增长21%的营业收入。显而易见的是,尽管未来的增长前景比最近的过去更加光明,时代天使的增速预计将比整个行业放缓。

The Bottom Line

最重要的事情是分析师增加了它对下一年每股亏损的估计。令人欣慰的是,营收预测未发生重大变化,业务仍有望比整个行业增长更快。共识价格目标稳定在28.50美元,最新估计不足以对价格目标产生影响。

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also upgraded their revenue estimates, although our data indicates it is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

最重要的是,情绪没有发生重大变化,分析师们重申业务的表现与之前的每股收益预期一致。幸运的是,他们也提高了营业收入的预期,尽管我们的数据显示,与整个行业相比,预计表现将更差。共识价格目标没有真正改变,这表明业务的内在价值没有随着最新的估计发生重大变化。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Angelalign Technology analysts - going out to 2026, and you can see them free on our platform here.

话虽如此,公司盈利的长期趋势比明年更为重要。我们有多个时代天使分析师的估计数据,可以到我们的平台上免费查看。

Don't forget that there may still be risks. For instance, we've identified 2 warning signs for Angelalign Technology that you should be aware of.

不要忘记,仍然可能存在风险。例如,我们已经发现时代天使存在2个警示信号,你应该注意。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发